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Objective: Hyponatremia and rapid correction of hyponatremia can lead to neurological 
abnormalities. The objective of the study was to determine whether plasma sodium 
concentrations (Na+) and speed of correction of hyponatremia are significantly associated with 
neurological abnormalities in foals. 
Design: Retrospective cohort study 2012-2016 
Setting: Equine hospital 
Animals: 109 foals less than 6 months old with hyponatremia (Na+ concentration ≤125mmol/L)  
Interventions: Case records were reviewed for any foal with hyponatremia. Clinicopathological 
findings, presence or absence of neurological signs on the day of the lowest Na+ concentration 
measured and also the following 5 days, diagnosis and outcome were recorded and changes in 
Na+ concentration per hour were calculated for up to 5 subsequent days. Logistic regression 
was used to assess the association between presence or absence of neurological signs, Na+ 
concentration, other known risk factors for neurological dysfunction in foals and possible 
confounders. 
Measurements and Main Results: In the final multivariable model only Na+ (OR 0.86; 95% CI 
0.79-0.95; p=0.002) and BUN concentrations (OR 1.04; 95% CI 1.02-1.06; p=0.001) were 
significantly associated with neurological signs. Changes in Na+ concentrations per hour were 
not associated with neurological signs on any day after the lowest Na+ concentration had been 
measured (p=0.18-0.82) and development of new neurological signs following correction of 
hyponatremia were not reported in any foal. 
Conclusions: Na+ concentrations were associated with the development of neurological signs 
in hyponatremic foals. Increased BUN concentrations might contribute to neurological 
dysfunction but further studies are necessary to confirm or refute these findings. 
 
List of abbreviations: 
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AG: Anion gap 
95% CI: 95% confidence interval 
Ca2+: Total plasma calcium concentration 
Cl-: Plasma chloride concentration 
cOsmol: Calculated plasma osmolality 
efOsmol: Effective plasma osmolality 
K+: Plasma potassium concentration 
Na+: Plasma sodium concentration 
OR: Odds ratio 
PAS: Perinatal asphyxiation syndrome 
SIRS: Systemic inflammatory response syndrome  
SID: Strong ion difference  
TCO2: Total carbon dioxide concentration  
 
Introduction 
Mild hyponatremia is frequently observed in foals presenting with a variety of disorders 
including enterocolitis, uroperitoneum, renal disease, rhabdomyolysis, pneumonia, perinatal 
asphyxiation syndrome (PAS), and sepsis with intestinal disease being the most common cause 
of hyponatremia in foals.1-5 Hyponatremic encephalopathy is a relatively infrequent 
complication that occurs secondary to changes in the plasma osmolality and subsequent 
development of cerebral edema.6 The presence of neurological complications depends on the 
severity of the hyponatremia and the time over which the abnormality develops. In critically ill 
foals, several metabolic abnormalities with the potential to influence neurological function 
often co-exist, making it difficult for the clinician to identify the most important abnormalities. 
Apart from plasma sodium concentrations (Na+), hypoglycemia, hyperkalemia, hypocalcemia, 
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systemic inflammatory response syndrome (SIRS), and sepsis have all been implicated.7 A 
further complicating factor is that rapid correction of chronic hyponatremia can lead to osmotic 
demyelination syndrome with lasting neurological impairment or even death, as described in 
the literature in other species.8 Although not described in the literature, isolated anecdotal 
reports in foals exist and most clinicians endeavour to correct asymptomatic hyponatremia of 
chronic or unknown duration gradually. Current guidelines for human patients recommend 
limiting the increase of Na+ concentrations to <0.5-1.0mmol/L/h or <10mmol/L/day, regardless 
of chronicity.8, 9 Apart from case reports and small case series,1, 2, 10 only one study has 
described hyponatremic encephalopathy in 11 foals.6 In this study, the influence of other 
concomitant electrolyte and glucose abnormalities was not taken into consideration, probably 
at least in part due to the small number of cases. Currently, there is no information available 
whether any concurrent abnormalities might interact with Na+ concentrations, either decreasing 
or increasing the likelihood of neurological dysfunction. In addition, apart from anecdotal 
reports, there is no information available about how speed of correction of hyponatremia 
influences neurological symptoms in foals. 
 
The study therefore tested the hypothesis that Na+ concentrations and speed of correction of 
hyponatremia are significantly associated with neurological abnormalities in foals. 
 
Material and Methods  
The Clinical Research Ethics Board of the Royal Veterinary College granted ethical approval 
for this study. Inclusion criteria for the study were the presence of hyponatremia (sodium 
concentration of ≤125mmol/L)8, 9 in foals less than 6 months of age at any stage during 
hospitalization.  
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Medical records from Hagyard Equine Medical Institute in Lexington, Kentucky, USA from 
2012-2016 were reviewed for foals matching the inclusion criteria. Data collected from patient 
records included signalment, presenting complaint, clinicopathologic findings, final diagnosis 
and outcome. The date of the lowest Na+ concentration was identified and neurological status 
and laboratory parameters for this date and up to 5 subsequent days were recorded. The time 
when sodium concentrations had been measured were recorded as stated on the print out of the 
laboratory results sheet and the change of the Na+ concentration per hour from one 
measurement to the next was calculated. Whenever available, changes over 24h were 
calculated. Measurements were routinely performed within 30min of blood collection. Strong 
ion difference (SID = Na+ + plasma potassium (K+) – plasma chloride (Cl-) concentrations), 
anion gap (AG = Na+ + K+ – Cl- - total carbon dioxide (TCO2)),
11 calculated plasma osmolality 
(cOsmol = 2Na+ (mmol/L) + glucose (mg/dL)/18 + BUN (mg/dL)/2.8) and effective plasma 
osmolality (efOsmol = 2Na (mmol/L) + glucose (mg/dL)/18) were calculated. 
 
Based on clinical signs recorded on the day of blood collection, foals were categorized as 
neurologically normal or abnormal. In addition, their neurological status was subsequently 
assessed and recorded each day for up to 5 days. The following clinical signs were considered 
neurologically abnormal: obtundation, ataxia, presence of cranial nerve deficits, 
hyperreactivity, needing assistance to stand and recumbency (if the foal had been able to rise 
and stand before development of signs and other reasons such as orthopaedic disease or colic 
had been excluded), protruding tongue, continuous chewing motions, decreased suckle reflex 
(if normal prior to the development of clinical signs) and partial or generalized seizure activity. 
Foals showing neurological signs during the first 24h of life were excluded. Presence or 
absence of SIRS was assessed as previously described12 on the day of the lowest recorded Na+ 
concentration. In brief, presence or absence of 6 criteria (fever or hypothermia; tachycardia; 
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tachypnea; leucocytosis, leucopenia or >5% band cells; hyperlactatemia and hypoglycaemia) 
was noted with different cut off points being used for 3 different age groups (<3 days old; 4-
14 days old; 15 days – 6 months old).12 Sepsis was defined as foals with either a positive blood 
culture or presence of SIRS and a documented infection. A documented infection was defined 
as a positive microbiological culture or cytological evidence of bacteria from a physiologically 
sterile body site. The final diagnosis was listed as recorded by the clinician in charge of the 
case; in several animals, multiple diagnoses were recorded. Foals with a diagnosis of head 
trauma, suspicion of toxicity or infectious meningitis were excluded. The neurological outcome 
was classified as normal at discharge, improved but residual abnormalities, unchanged 
abnormalities and worsened abnormalities. The overall outcome was categorized as discharged 
from hospital, euthanized, or died.  
 
Statistical Analysis  
Data were analysed using a commercially available software program (IBM SPSS Statistics 
22). Continuous data were expressed as mean ± standard deviation or median and range 
(minimum to maximum) and categorical data were presented as numbers and percentages. 
Normality of the data was assessed using the Shapiro-Wilk test. A Mann Whitney U test (all 
continuous data were not normally distributed) was used to investigate an association between 
presence or absence of neurological signs and SID, AG, cOsmol and efOsmol. In addition, the 
association between outcome and Na+ concentration on admission and the lowest Na+ 
concentration during hospitalization was tested. A χ2 test Exact test (categorical data) was used 
to investigate the association between outcome and presence or absence of neurological signs.  
 
Logistic regression was used to assess the association between presence or absence of 
neurological signs, plasma Na+ concentration, and possible confounding factors (age, gender, 
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diagnosis, blood glucose, K+, Cl-, TCO2, total plasma calcium (Ca
2+), blood urea nitrogen 
(BUN) and creatinine concentrations and presence or absence of SIRS and sepsis) on the day 
the lowest plasma Na+ concentration was measured. Only factors with a p-value <0.1 in the 
univariable analysis were assessed in the multivariable analysis using backward elimination 
procedure. As Na+ concentration is the main determinant of cOsmol and efOsmol, and Na+, 
Cl- , K+ and TCO2 concentrations are used to calculate SID and AG, none of the calculated 
values were included into the multifactorial analysis. Results of the final multivariable logistic 
regression analysis were displayed as odds ratio (OR) and 95% confidence interval (95% CI). 
Statistical significance was set at p≤0.05 for all analyses. 
 
Results 
Revision of medical records identified 114 foals that matched the inclusion criteria. Five foals 
<24h of age were excluded as the neurological signs were consistent with PAS and 109 foals 
were included in the final study. This constituted approximately 3.6% of foals of that age that 
presented to the hospital. The predominant breed was Thoroughbred (n=78), two foals were 
Standardbreds and in 29 foal the breed was not recorded. Comparison with the overall hospital 
population, which consists to 75-80% of Thoroughbreds, was difficult to the large number of 
foals without recorded breed. Of the 109 foals, 43% (n=47/109) were males, 37% (n=40/109) 
were females and in 20% (n=22/109) gender was not recorded. The median age at admission 
was 7 days (range 0-180 days). Most foals had multiple presenting complaints with the most 
common presenting complaint being diarrhea (37%, n=40/109), followed by lethargy and 
inappetence (15%, n=16/109) and colic or abdominal distension (13%, n=14/109). 
Neurological signs apart from depression were noted in 4 foals prior to admission; all 
consisting of seizure activity.  
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Colitis/enterocolitis was the most common diagnosis (45%, n=49/109), followed by pneumonia 
(10%, n=11/109), a clinical diagnosis of sepsis (9%, n=10/109; only one of these met the study 
criteria for sepsis), uroperitoneum (8%, n=9/109), renal disease (5%, n=5/109), meconium 
impaction (4%, n=4/109), perinatal asphyxia syndrome (3%, n=3/109), immune-mediated 
hemolytic anemia/neonatal isoerythrolysis (3%, n=3/109) and 22/109 foals (20%) with other 
conditions. Some foals had multiple diagnoses. Thirty foals were classified as having SIRS; 
however, only 9 foals had plasma lactate concentrations recorded on the relevant day while 10 
foals had no white blood cell count measured at this time point. Blood cultures were performed 
in 41 foals; 41% (n=17/41) were positive. Overall, 27 foals were considered septic according 
to the study’s definition. 
 
In 77 (71%) foals the lowest Na+ concentration was measured on admission while in 32 (29%) 
foals the lowest concentration was documented during hospitalisation. Two foals presented 
with Na+ concentrations ≤100mmol/L, thirteen with concentrations >100 and ≤110mmol/L, 
fifteen with concentrations >110 and ≤115mmol/L, thirty with concentrations >115 and 
≤120mmol/L and fifty-four with concentrations >120 and ≤125mmol/L. Electrolyte 
concentrations in neurologically normal and abnormal foals are displayed in Table 1. In 66% 
(n=72/109) of foals no neurological abnormalities were recorded. Twenty-two percent 
(n=24/109) presented with neurological signs on admission and 12% (n=13/109) developed 
neurological signs during hospitalisation (total 34% n=37/109). Colitis/enterocolitis was also 
the most common diagnosis in foals with neurological signs (n=19), followed by a clinical 
diagnosis of sepsis (n=5), renal disease (n=4), uroperitoneum (n=1), pneumonia (n=1) and 
other conditions (n=7). Most foals showed more than one neurological abnormality. In 
decreasing frequency, the following neurological signs were recorded: obtundation (n=10), 
ataxia (n=10), generalized seizure-like activity (n=10), partial seizure-like activity (n=9),  
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decreased suckle reflex (n=7), hyperreactivity (n=5), central blindness (n=4), a head tilt (n=2), 
opisthotonus (n=2), continuous chewing/tongue movement (n=2), grimacing (n=2), circling 
(n=1), head pressing (n=1) and one foal was comatose. By the time of discharge/death, 25/37 
foals were reportedly neurologically normal (68%; 14 discharged from the hospital; 8 
euthanized; 3 died), 6 had neurologically improved (16%; all discharged from the hospital with 
normal Na+ concentrations), one was neurologically unchanged (2%; died) and in 5 the 
neurological status had worsened (14%; 3 euthanized, 2 died). Four of these 5 cases had Na+ 
concentrations of ≥125mmol/L at the time of death/euthanasia while in one foal only a minimal 
increase from 118 to 119mmol/L over 24h was recorded before it died. The maximal recorded 
increase in Na+ concentration was 1.75mmol/L/h in one foals and <0.5mmol/L/h for all others. 
Overall 67% (n=73/109) of foals were discharged, 23% (n=25/109) were euthanized and 10% 
(n=11/109) died.  
 
In a univariable analysis, neurological signs were significantly associated with Na+ 
concentrations (OR 0.85; 95% CI 0.78-0.92; p<0.001; Figure 1). Factors assessed in the 
multivariable model (p<0.1) were age, Cl-, K+, TCO2, BUN and creatinine concentrations. 
Gender, diagnosis, total Ca2+ and glucose concentration and presence or absence of SIRS and 
sepsis and diagnosis were not included (p>0.1). In the final multivariable model only Na+ (OR 
0.86; 95% CI 0.79-0.95; p=0.002) and BUN concentrations (OR 1.04; 95% CI 1.02-1.06; 
p=0.001) were significantly associated with neurological signs.  
 
Changes in Na+ concentrations per hour were not associated with neurological signs on any 
day after the lowest Na+ concentration had been measured (p=0.18-0.82) and development of 
new neurological signs following correction of hyponatremia were not reported in any foal. 
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On the day of the lowest Na+ concentration, SID and cOsmol were not significantly different 
between foals with neurological signs (SID: 38mmol/L (21-56mmol/L); cOsmol: 
257mOsmol/kg (228-309mOsmol/kg)) and those without (SID: 37mmol/L (21-51mmol/L); 
p=0.53; cOsmol: 260mOsmol/kg (224-286mOsmol/kg); p=0.62). In contrast, efOsmol and AG 
were significantly different between foals with neurological signs (efOsmol: 240mOsmol/kg 
(192-264mOsmol/kg); AG: 19mmol/L (6.3-41mmol/L)) compared to those without (efOsmol: 
252mOsmol/kg (214-264mOsmol/kg) p<0.001; AG: 13mmol/L (-6-39mmol/L); p<0.001). 
 
Neither admission, nor the lowest Na+ concentration measured during hospitalization were 
associated with outcome (admission Na+ concentration non-survivors: 120mmol/L (105-
150mmol/L) versus survivors 123mmol/L (96-149mmol/L), p=0.85; lowest Na+ concentration 
non-survivors 119mmol/L (105-125mmol/L) versus survivors 122mmol/L (94-125mmol/L), 
p=0.39). In contrast, presence of neurological signs in hyponatremic foals at any stage during 




Results of this study corroborate and expand findings of the few previous studies conducted on 
hyponatremia in foals. As expected, Na+ concentrations were significantly associated with 
signs of neurological dysfunction in the multivariable analysis. In people, iso- and hypertonic 
hyponatremia can occur secondary to severe hyperglycemia, pseudohyponatremia and 
mannitol use8 but those conditions are rarely encountered in horses. In foals, most cases of 
hyponatremia are likely to be accompanied by hypotonicity as Na+ concentrations and 
associated anions are the largest determinants of efOsmol. This assumption was supported by 
the fact that calculated efOsmol was significantly lower in foals with neurological signs 
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compared to those without. Ideally, efOsmol is measured, rather than calculated, but in most 
clinical situation good correlation between both can be assumed.13 Exceptions are cases with 
the presence of unidentified osmoles which remain undetected unless osmolality is measured.14 
This has anecdotally been reported in neonatal foals but the frequency of the condition and its 
effects on the foal still remain to be determined. The development of neurological signs does 
not only depend on the degree of hyponatremia and hypotonicity but also on the speed with 
which it develops. The more rapidly hyponatremia ensues, the more likely it is that neurological 
complications will arise. The duration of hyponatremia also determines how an animal 
responds to treatment. While acute hyponatremia (<48h duration) can be corrected relatively 
quickly, fast correction of chronic hyponatremia carries a risk of osmotic demyelination.8 
Unfortunately, information about duration of the condition is difficult to accurately establish 
in clinical cases, even in human patients, and more so in a retrospective study. Due to this 
uncertainty current recommendations are to treat chronic and acute hyponatremia equally 
conservatively if Na+ concentration are <120mmol/L. In symptomatic cases, an increase of 4-
8mmol/L (approximately 5% increase in Na+ concentration) over the first 6h of therapy often 
alleviates clinical signs and further increases should not exceed a total of 10mmol/L/d.8, 15 In 
cases with no neurological symptoms, a gradual increase by 10% per day should be targeted. 
The average correction rate in this study was at most time points <0.5mmol/L/h, indicating that 
clinicians are well aware of the issue of rapid correction of Na+ concentrations and aimed to 
avoid any possible complications. In this study, no case of osmotic demyelination was 
documented or suspected, despite increases in Na+ concentrations of up to 8.3mmol/L/h in 
individual animals. However, these large changes occurred in animals in which measurements 
were taken relatively closely to each other and the total change over 24h was often not known. 
In addition, the duration of hyponatremia was not known this cannot be taken as indication that 
a gradual increase of the Na+ concentrations is not necessary in foals. In addition, foals were 
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only followed until discharge and any signs that might have occurred later were not recorded. 
Due to the rarity of osmotic demyelination, it will be very difficult to establish the risk in foals 
in a prospective study and in the absence of species-specific recommendations, following 
guidelines for human patients might be advisable. 
 
Interestingly, results of the study suggest that high BUN concentrations were associated with 
the development of hyponatremic encephalopathy. Possible reasons might include a direct 
effect of BUN on the brain or BUN acting as a marker of renal insufficiency. It is also possible 
that, although statistically associated with neurological signs, the BUN concentration has no 
causal effect on neurological dysfunction. Uremic encephalopathy is well reported in people 
with acute or chronic renal failure and has been described in horses.16-18 Symptoms are thought 
to be caused by a number of uremic neurotoxins, largely derived from protein and amino acid 
metabolism such as urea guanidines, uric acid, polypetides and other substrates that are able to 
cross the blood brain barrier. Only 14% of foals with neurological signs presented with diseases 
directly relating to the urinary system. However, 79% of foals with neurological signs also had 
increased BUN concentrations largely secondary to hypovolemia or, less commonly, placental 
insufficiency in neonates. In 2 case series, all foals with hyponatremic encephalopathy were 
diagnosed with renal disease1, 6 highlighting the possibility that either BUN or other 
unidentified metabolites usually cleared by the kidney contribute to the development of 
hyponatremic encephalopathy. The differences in primary disease processes might be 
explained by different inclusion criteria and different geographical locations. In contrast to 
blood glucose, BUN concentrations are not included in the calculation of efOsmol. Urea 
transporters facilitate diffusion across systemic capillaries and most cell membranes nearly as 
rapidly as water, rendering the molecule osmotically ineffective.19 In contrast to other cell 
membranes, the blood brain barrier has a reflection coefficient of 0.5 for BUN, allowing it to 
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act as osmotic agent.19 It also acts as a diuretic, increasing renal excretion of free water, which 
in turn increases Na+ concentrations. One would therefore assume that increased BUN 
concentrations, if solely acting as an osmotic substance, would counteract the development of 
neurological signs rather than fostering it. In fact, BUN has been suggested as treatment for eu- 
or hypervolemic hyponatremia as it might have cytoprotective and osmoprotective properties. 
By creating an osmotic gradient across the blood brain barrier, it promotes water efflux from 
the brain.19 An additional benefit of treatment with BUN is that overcorrection of hyponatremia 
resulted in significantly lower neurological impairment and mortality than the other treatment 
options.20 Indeed, in people, a protective effect of increased BUN concentrations against the 
development of osmotic demyelination following rapid correction of hyponatremia has been 
described.19, 20 Part of this effect might be based on a substantially enhanced re-uptake of 
organic osmoles into the brain, particularly myoinositol, which has been demonstrated in 
uremic animal models.19, 21, 22 It seems therefore more likely that either BUN or unidentified 
metabolites act as neurotoxins, enhancing the effect of hyponatremia. 
 
Surprisingly, blood glucose concentrations had no effect on the development of neurological 
signs. In foals, severe hypoglycemia has been most commonly associated with neurological 
signs and seizure-like activity presumed to be due to neuronal energy depletion. Only one foal 
in this study had severe hypoglycemia (1.4mmol/L; 26mg/dL) and this foal showed no 
neurological signs. Interestingly, in a recent study in severely hypoglycemic calves (blood 
glucose concentrations <2.0mmol/L; <36mg/dL), only 10% displayed neurological symptoms, 
highlighting that neurological complications associated with low glucose concentrations are 
probably rare and mainly occur with extreme hypoglycaemia.23 Severe hyperglycemia can also 
lead to neurological complications secondary to hyperosmolarity and cellular dehydration. 
However, hyperglycemia of the required severity is rarely observed in horses and the highest 
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glucose concentration measured in this study was 20.8mmol/L; 374mg/dL. The absence of 
cases with extremely low or high glucose values probably explains the lack of an association 
with neurological symptoms. Although glucose concentrations influence efOsmol, the 
contribution is comparatively low and largely negligible in comparison to Na+ concentrations. 
 
Different to studies in people and cats and dogs, but in accordance with another study on 
hyponatremia in foals, Na+ concentrations were not associated with outcome.6, 24, 25 It has 
frequently been assumed that marked deviations from the tightly regulated normal Na+ 
concentrations are a marker of disease severity, rather than a direct contributor to mortality.25 
However, recent studies in critically ill people have identified dysnatremias as independent 
predictors of mortality24, 26 and a study in cats and dogs found a linear association between the 
magnitude of hyponatremia and case fatality. Only hyponatremic foals were included in the 
study, as was the case in Collins’ study,6 and a comparison with normonatremic animals could 
therefore not be conducted. It is possible that comparison with a normonatremic group would 
have identified an influence on outcome. Further investigations in foals might therefore be 
warranted.  
 
In contrast, outcome was associated with the presence of neurological signs. This is in line with 
studies in people where hyponatremia complicated by hyponatremic encephalopathy is 
associated with a poor outcome.27 This is interesting as neurological signs resolved or improved 
in 84% of foals, coinciding with increases in the Na+ concentrations, yet 44% of the foals in 
which neurological signs resolved still died or were euthanized. This could suggest that 
hyponatremia and associated neurological signs are a reflection of disease severity. While 
correction of hyponatremia might alleviate neurological signs, the underlying disease process 
can still prove to be fatal. In contrast to people, no widely accepted disease severity scores are 
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available in horses although scores for prediction of sepsis and prognosis have been reported 
for neonatal foals.28-30 A disease severity score would have been useful to assess whether the 
degree of hyponatremia correlates with disease severity. No correlation between neurological 
signs and presence of SIRS or sepsis was found. This is similar to people, where inflammation 
or infection do not seem to be significant risk factors for development of hyponatremic 
encephalopathy.27 However, the number of foals with SIRS might have been underestimated 
in this study due to missing data, and an association cannot be categorically excluded.  
 
As in any retrospective study, there are several limitations. The classification of presence or 
absence of neurological signs and their description relied on notes made in the clinical records. 
It is possible, that subtle abnormalities were not recorded and that interpretation of clinical 
signs differed between clinicians. Foals were also only followed to discharge from the hospital 
and any neurological signs occurring after this time point would not have been accounted for. 
In neonatal foals, several disease processes can cause similar clinical signs. Particularly PAS 
is often associated with neurological dysfunction ranging from lack of coordination, poor 
tongue control and absent suckle reflexes to generalized seizure-like activity. Every effort was 
made to exclude foals that presented with signs consistent with PAS by only including animals 
that were normal at birth and developed neurological signs during the disease process. 
Unfortunately, measures of arterial oxygenation and pH and were not available for the majority 
of foals and could therefore not be included in the multivariable analysis. Hypoxic brain 
damage in human patients is most commonly encountered in the form of hypoxic-ischemic 
encephalopathy in neonates or following cardiac arrest. In both conditions, ischemia plays a 
vital part in the pathophysiology.31, 32 Animal models suggest that 0-8% inhaled oxygen, 
corresponding approximately to a PaO2 of <40mmHg, produce some degree of neurological 
dysfunction if perfusion remains normal.33 As foals with PAS and neurological signs were 
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ruled out and respiratory disease was only documented in 1 case with neurological signs, it is 
unlikely that hypoxia was the reason for the observed neurological signs. However, a 
contributing role cannot be excluded and ideally measurements of PaO2 would have been 
included. Intra- and extracellular pH can significantly influence neurological function34 and 
would ideally have been included as well. However, even a single brief episode of seizure-like 
activity can cause severe acidosis and hyperlactatemia and therefore cause and effect would 
have been difficult to differentiate in foals with neurological signs.35 Due to the retrospective 
nature, the volume status (hypo-, normo-, or hypervolemic) could not be assessed and any 
effect this might have on symptoms was therefore not accounted for. 
 
In conclusion, Na+ and BUN concentration are significantly associated with neurological 
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Figure 1: Median and interquartile range of lowest sodium (Na+) concentration measured 
during hospitalization grouped by presence or absence of neurological signs at the same time 
point. There was a statistically significant association between presence of neurological signs 

















Table 1: Comparison of clinicopathological parameters between foals < 6 months old with hyponatremia (≤125mmol/L) with and without 
neurological abnormalities on the day the lowest sodium concentration was measured and on up to four subsequent days. 
 Day of lowest Na concentration Day 1 after lowest Na 
concentration 
Day 2 after lowest Na 
concentration 
Day 3 after lowest Na 
concentration 
Day 4 after lowest Na 
concentration 







































































































































18 (5-85); 49 
(14-237); n=32 








































































Table 2: Association between presence and absence of neurological signs and survival to 
discharge from the hospital in foals < 6 months old with hyponatremia (≤125mmol/L). 
Statistical significance was set at a p-value of <0.5.  
 Non-survivors Survivors Total 
No neurological signs present 19 53 72 
Neurological signs present 17 20 37 
Total 36 73 109 
P-value   0.034 
 
 
 
